Skip to main content
OIDA Image Collection
Filters:
Reset 
Information about NUCYNTA ER. It is titled "NUCYNTA ER demonstrated powerful efficacy in DPN pain". There is a line graph at the center of the image titled "Mean pain intensity score from baseline over time with NUCYNTA ER or placebo." The x-axis shows time in weeks. The y-axis is labeled "Mean NRS Score (SE)" with a range of values between 2 and 8. The line starts at a value of between 7 and 8 and decreases rapidly to a value of between 3 and 4 over the first three weeks in a section of the graph labeled "Open-label (OL) period". For weeks 3 through 12 the line graph remains steady at values between 3 and 4. <br /><br />Text below the graph indicates that all randomized patients had a mean pain intensity score of 3.5 at the start of the DB period and that improvement in pain intensity from the OL period in the NUCYNTA ER group was maintained through the 12-week double-blind period. <br /><br />At the bottom of the page there is a navigation menu and "Opioid Efficacy" appears to be selected. The image also shows a red side bar with the NUCYNTA ER logo and selected important safety information. At the bottom of the sidebar there is a button that says "Click here for more comprehensive safety information".

Description

Information about NUCYNTA ER. It is titled "NUCYNTA ER demonstrated powerful efficacy in DPN pain". There is a line graph at the center of the image titled "Mean pain intensity score from baseline over time with NUCYNTA ER or placebo." The x-axis shows time in weeks. The y-axis is labeled "Mean NRS Score (SE)" with a range of values between 2 and 8. The line starts at a value of between 7 and 8 and decreases rapidly to a value of between 3 and 4 over the first three weeks in a section of the graph labeled "Open-label (OL) period". For weeks 3 through 12 the line graph remains steady at values between 3 and 4.

Text below the graph indicates that all randomized patients had a mean pain intensity score of 3.5 at the start of the DB period and that improvement in pain intensity from the OL period in the NUCYNTA ER group was maintained through the 12-week double-blind period.

At the bottom of the page there is a navigation menu and "Opioid Efficacy" appears to be selected. The image also shows a red side bar with the NUCYNTA ER logo and selected important safety information. At the bottom of the sidebar there is a button that says "Click here for more comprehensive safety information".

We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.

Information copied to your clipboard:

"Information about NUCYNTA ER. It is titled "NUCYNTA ER demonstrated powerful efficacy in DPN pain". There is a line graph at the center of ...